Hester Biosciences Stock Prediction 2026: Expert Analysis, Forecast Scenarios and Full Stock Review

The Hester Biosciences stock prediction for 2026 from leading brokerages covers a range reflecting sector dynamics, earnings trajectory and the macro environment. All estimates may or may not be achieved. Treat any Hester Biosciences share price prediction as one data point and not as a guarantee of future performance.

This article reviews every dimension of the Hester Biosciences stock forecast analysts are tracking, including key drivers, bull and bear scenarios and the primary risks. Verify all figures with the latest brokerage reports before any investment decision.

Click Here – Get Free Investment Predictions

What Analysts Predict for Hester Biosciences Stock in 2026

Analyst consensus on the Hester Biosciences stock prediction for 2026 is tracked by leading brokerages. The table below shows the latest available data from JM Financial and ICICI Securities. All figures are sourced from publicly available research and should be verified before publishing.

Brokerage	Rating	Hester Biosciences Stock Prediction (Rs)	Updated
JM Financial	Buy	Rs 2450	2026
ICICI Securities	Neutral	Rs 2250	2026
Analyst Consensus	–	Rs 2350	2026

The analyst target range for Hester Biosciences reflects genuine difference of opinion on demand recovery, margin trajectory and sector headwinds. The implied upside in the Hester Biosciences stock forecast from the current price of Rs 2,049.2 may or may not be realised by end of 2026.

Hester Biosciences Company Overview

Hester Biosciences is a significant player in India's pharmaceutical industry with a presence across domestic formulations, US generics and specialty segments. The Hester Biosciences stock prediction for 2026 reflects both the pipeline growth potential and regulatory risk.

Metric	Value
NSE Ticker	HESTERBIO
Sector	Pharmaceuticals and Healthcare
CMP	Rs 2,049.2 (2026)
52 Week High	Rs 2,350
52 Week Low	Rs 1,239
Market Cap	Rs 1,754 Cr
P/E Ratio	37.4
Hester Biosciences Stock Prediction Consensus (12M)	Rs 2350

Hester Biosciences Stock Prediction by Time Horizon

Analysts split the Hester Biosciences share price prediction across time frames as near-term drivers differ materially from the long-term view.

Short-Term Hester Biosciences Stock Prediction

The near-term Hester Biosciences stock forecast reflects current sentiment, sector news and upcoming earnings prints. Key support and resistance levels around Rs 2,049.2 are being watched closely. A short-term Hester Biosciences share price prediction carries the most uncertainty of any time horizon.

12-Month Hester Biosciences Stock Prediction

JM Financial targets Rs 2450 (Buy) and ICICI Securities targets Rs 2250 (Neutral). Most desks refresh their Hester Biosciences stock forecast within two to four weeks of each quarterly earnings print. The Hester Biosciences share price prediction should be verified against the most recent analyst reports.

Long-Term Hester Biosciences Stock Prediction

The long-term outlook for Hester Biosciences is built on assumptions about demand recovery, margin expansion and revenue diversification in the Pharmaceuticals and Healthcare sector. Long-term price targets carry the most uncertainty and should be treated as directional guidance only.

Hester Biosciences Stock Forecast: Key Factors

The following four factors appear consistently in analyst research on Hester Biosciences and are the primary inputs into the bull and bear case scenarios.

US Generic Revenue

US generics revenue is the most watched metric in the Hester Biosciences stock forecast. USFDA approval timelines and price erosion rates directly affect the Hester Biosciences share price prediction from most research desks.

Domestic Formulations Growth

Domestic formulation growth provides a stable base that supports the Hester Biosciences stock prediction even when export growth faces headwinds.

R&D Pipeline

The depth and commercialization pace of the R&D pipeline is a key variable in the long-term Hester Biosciences share price prediction. New product approvals are cited as catalysts for the Hester Biosciences stock prediction.

EBITDA Margin

Sustained EBITDA margin expansion is typically the basis for the bullish Hester Biosciences stock forecast. Margin recovery strengthens the Hester Biosciences share price prediction from most research desks.

Hester Biosciences Stock Prediction: Bull and Bear Scenarios

Scenario	Hester Biosciences Stock Prediction	Key Conditions
Bull Case	Rs 2450	Strong execution, margin improvement, favourable macro and sector re-rating
Base Case	Rs 2350	Steady performance, gradual recovery, margins hold, growth on track
Bear Case	Rs 1239	Demand deterioration, margin pressure, sector de-rating and macro headwinds

The bull case Hester Biosciences stock forecast of Rs 2450 assumes most positive variables converge. The base case of Rs 2350 is the analyst consensus and may or may not be achieved.

How Analysts Are Reading the Hester Biosciences Stock Story

Analyst reviews of the Hester Biosciences share price prediction highlight the company's core strengths in Pharmaceuticals and Healthcare alongside near-term headwinds from macro uncertainty, competitive pressure and sector-level challenges. Overall the analyst consensus for Hester Biosciences is built on real business strengths set against real risks.

Key Risks to the Hester Biosciences Stock Prediction

USFDA Regulatory Risk

Import alerts and warning letters from the USFDA are the most significant risks to the Hester Biosciences stock prediction. A facility closure would force an immediate sharp revision to the Hester Biosciences share price prediction.

Price Erosion in the US

Pricing pressure in US generics compresses the revenue per product and affects the Hester Biosciences stock forecast. Aggressive price erosion pushes the Hester Biosciences share price prediction toward the bear case.

R&D Execution Risk

Delays in clinical trials or approval failures affect the Hester Biosciences stock prediction. The Hester Biosciences share price prediction is particularly sensitive to key pipeline asset announcements.

Currency Risk

A strengthening rupee against the dollar reduces export realisation and affects the Hester Biosciences stock forecast. Currency risk is embedded in conservative Hester Biosciences share price prediction models.

How to Monitor the Hester Biosciences Stock Forecast

Track the Hester Biosciences share price prediction consensus quarterly. After every earnings release, most brokerages revise their Hester Biosciences stock forecast within two weeks. Comparing the revised analyst target to the previous estimate tells you whether sentiment on Hester Biosciences is improving or deteriorating.

Compare the current price of Rs 2,049.2 with the analyst target range of Rs 2450 to Rs 2250. A wide target band reflects genuine uncertainty on Hester Biosciences, so position size should reflect that range rather than the midpoint alone.

Review the Hester Biosciences share price prediction every quarter against key business metrics for the Pharmaceuticals and Healthcare sector. A single estimate from any analyst is a point-in-time view and should be treated as one input among many when making any investment decision.

Check Live Hester Biosciences Fundamentals on the Univest Screener

Conclusion

The Hester Biosciences stock prediction for 2026 reflects the analyst community's assessment of Hester Biosciences's competitive position, earnings trajectory and macro environment. JM Financial holds a Buy stance with a target of Rs 2450 while ICICI Securities has a Neutral rating with a target of Rs 2250, giving an analyst consensus of Rs 2350.

The Hester Biosciences stock forecast is set against near-term risks that make the Hester Biosciences share price prediction range wide. Investors should verify any estimate with the latest brokerage reports before using it as an investment reference. The analyst forecast will be revised after every quarterly result, so tracking how the Hester Biosciences share price target changes over time is more valuable than relying on any single estimate.

Investments in securities are subject to market risk. This content is for educational purposes only and does not constitute investment advice.

Download the Univest iOS App or Univest Android App to track live analyst targets, price movements and research updates for Hester Biosciences in real time.

Frequently Asked Questions on Hester Biosciences Stock Prediction 2026

What is the Hester Biosciences stock prediction for 2026?

Ans. The Hester Biosciences stock prediction for 2026 is based on analyst consensus from JM Financial and ICICI Securities. The consensus target is Rs 2350. All estimates may or may not be achieved.

Is the Hester Biosciences stock prediction bullish or bearish?

Ans. JM Financial has a Buy rating with target Rs 2450. ICICI Securities has a Neutral rating with target Rs 2250. The Hester Biosciences stock forecast reflects genuine analyst diversity of opinion.

What is the Hester Biosciences share price prediction based on fundamentals?

Ans. The Hester Biosciences share price prediction rests on the US generic pipeline, domestic growth, EBITDA margin and regulatory compliance track record. Analysts tracking Hester Biosciences closely cite these as the primary drivers of the 2026 outlook.

What is the long-term Hester Biosciences stock prediction?

Ans. The long-term outlook assumes Hester Biosciences sustains its core business drivers over a multi-year horizon. The 12-month consensus of Rs 2350 is the nearest reliable anchor point.

What are the key risks to the Hester Biosciences stock prediction?

Ans. The primary risks include sector-specific headwinds, macro uncertainty, regulatory changes and competitive pressure. Every analyst estimate for Hester Biosciences should be read alongside its risk assumptions.

What does the Hester Biosciences stock forecast say for 2026?

Ans. JM Financial: Buy target Rs 2450. ICICI Securities: Neutral target Rs 2250. These Hester Biosciences share price prediction estimates may or may not prove accurate.

Where can I track the latest Hester Biosciences stock prediction?

Ans. Track the latest analyst targets and price movements for Hester Biosciences on the NSE and BSE websites and on the Univest app and screener for live data.